← Leaderboards
Shannon L Hardie
University Of Virginia Charlottesville
$140,751
Attributed
$140,751
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.6K · FY2007–08$50K$37.5K$25K$12.5K$0
'07
'08
Funding mix
By agency
NIH$140,751 · 2
By mechanism
F31$78,285 · 1
F32$62,466 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Jay Hirsh$6,424,649
- Raghavendra G Mirmira$22,841,626
- Lukas K Tamm$22,130,390
- J David Castle$7,631,496
- Kenneth S.k. Tung$12,031,145
Others in their field
Top investigators on “Pharmacokinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$237,100,725
- Constance Ann Benson · University Of California, San Diego$151,891,628
- Richard L Schilsky · University Of Chicago$114,474,127
- Ronald T Mitsuyasu · University Of California Los Angeles$105,970,100
- Wafaa M. El-Sadr · Columbia University Health Sciences$91,574,471
- Myron S Cohen · Family Health International$91,263,426
Research focus
PharmacokineticsDrug AddictionNeurochemistryDecarboxylasesBehavioral Habituation /SensitizationDrosophilidaeEnzyme ActivityEnzyme Induction /RepressionPredoctoral InvestigatorTyramineBehavioral /Social Science Research TagCocaineCaenorhabditis ElegansBrainAnimalsBiological ModelsBiogenic AminesAnimal ModelAdoptedDesignBiochemicalComplexDopamineCo-Immunoprecipitations
Grant awards (5)
Identifying Dopamine Transporter Regulator Proteins in C. elegans$12,820
F32 · FY2008 · DA · contact PI
Identifying Dopamine Transporter Regulator Proteins in C. elegans$49,646
F32 · FY2007 · DA · contact PI
The Involvement of Tyramine in Cocaine Sensitization$27,235
F31 · FY2004 · DA
The Involvement of Tyramine in Cocaine Sensitization$26,431
F31 · FY2003 · DA
The Involvement of Tyramine in Cocaine Sensitization$24,619
F31 · FY2002 · DA